Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.

by Lars Daae Horvei, Sigrid K Brækkan, John-Bjarne Hansen
Published 2016-01-01

Role of microRNAs in Venous Thromboembolism

by Vânia M. Morelli, Sigrid K. Brækkan, John-Bjarne Hansen
Published 2020-04-01

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

by Hilde Jensvoll, Kristine Blix, Sigrid K Brækkan, John-Bjarne Hansen
Published 2014-01-01

White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.

by Kristine Blix, Hilde Jensvoll, Sigrid K Brækkan, John-Bjarne Hansen
Published 2013-01-01

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

by Stein Harald Johnsen, Bjarne K. Jacobsen, Sigrid K. Brækkan, John-Bjarne Hansen, Ellisiv B. Mathiesen
Published 2018-05-01

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study

by Trond Børvik, Line H. Evensen, Vania M. Morelli, Hasse Melbye, Sigrid K. Brækkan, John‐Bjarne Hansen
Published 2020-02-01

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding

by Håkon S. Johnsen, Kristian Hindberg, Esben Bjøri, Ellen E. Brodin, Sigrid K. Brækkan, Vânia M. Morelli, John-Bjarne Hansen
Published 2019-01-01

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study

by Erin Mathiesen Hald, Maja‐Lisa Løchen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njølstad, Sigrid K. Brækkan, John‐Bjarne Hansen
Published 2020-08-01

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study

by Jostein Lappegård, Trygve S. Ellingsen, Kristian Hindberg, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, Maja-Lisa Løchen, Sigrid K. Brækkan, John-Bjarne Hansen
Published 2018-04-01

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study

by Joakim K. Sejrup, Vania M. Morelli, Maja‐Lisa Løchen, Inger Njølstad, Ellisiv B. Mathiesen, Tom Wilsgaard, John‐Bjarne Hansen, Sigrid K. Brækkan
Published 2020-02-01

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study

by Erin M. Hald, Maja-Lisa Løchen, Jostein Lappegård, Trygve S. Ellingsen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njølstad, Sigrid K. Brækkan, John-Bjarne Hansen
Published 2020-07-01

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study

by Vânia M. Morelli, Joakim K. Sejrup, Birgit Småbrekke, Ludvig B. Rinde, Gro Grimnes, Trond Isaksen, John-Bjarne Hansen, Kristian Hindberg, Sigrid K. Brækkan
Published 2019-01-01

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

by Jasmijn F Timp, Sigrid K Braekkan, Willem M Lijfering, Astrid van Hylckama Vlieg, John-Bjarne Hansen, Frits R Rosendaal, Saskia le Cessie, Suzanne C Cannegieter
Published 2019-10-01

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort

by Benedikte Paulsen, Olga V. Gran, Marianne T. Severinsen, Jens Hammerstrøm, Søren R. Kristensen, Suzanne C. Cannegieter, Hanne Skille, Anne Tjønneland, Frits R. Rosendaal, Kim Overvad, Inger Anne Næss, John-Bjarne Hansen, Sigrid K. Brækkan
Published 2021-09-01

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort

by Inger Lise Gade, Sigrid K. Brækkan, Inger Anne Næss, John-Bjarne Hansen, Suzanne C. Cannegieter, Frits R. Rosendaal, Kim Overvad, Kristian Hindberg, Jens Hammerstrøm, Olga V. Gran, Anne Tjønneland, Marianne T. Severinsen, Søren R. Kristensen
Published 2018-04-01